FDA Inspection 970028 — Chongqing Carelife Pharmaceutical Co., Ltd.

Chongqing Carelife Pharmaceutical Co., Ltd. — FEI 3011903543

The FDA completed an inspection of Chongqing Carelife Pharmaceutical Co., Ltd. on May 19, 2016 in Chongqing. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 19, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chongqing (China)